Intro to Precision Antibody and Simbex

MTEC's Service Provider Webinar Series puts our members in front of the commercialization partners who can accelerate their programs.

Next Wednesday, May 6 at 1:00 PM., we're featuring two companies: Simbex and Precision Antibody.

First up, Dr. Jun Hayashi, President of Precision Antibody, will share how PA has built a 26-year track record as a global leader in antibody development — delivering polyclonals in as fast as 30 days, monoclonals (including fully human therapeutic mAbs) in 60, and a greater-than-95% success rate of producing antibodies that actually work in the intended application. Jun will walk through how rapid, application-driven antibody development compresses your timeline and protects your budget, whether you're advancing diagnostics, research tools, or therapeutics.

At 1:30 p.m, Simbex's CEO Greg Lange and Amaris Ajamil, Director of Quality and Regulatory Affairs, will tackle one of the most consequential, and most frequently misunderstood, questions in medical device development: how do you determine the right FDA regulatory pathway for your device? Their walk-through demystifies FDA classification, intended use and indications for use, and the primary U.S. regulatory pathways, then layers on a structured decision-making approach you can take back to your team.

Each session runs 30 minutes — 20 minutes of focused content plus 10 minutes of live Q&A. Hope you’ll join us.

Rick